Bevacizumab Gamma
ATC — · 2 markets · 3 records
Bevacizumab Gamma
Forms
GB 2 records · 2 strengths
- 7.5 mg/0.3 mLinjectionLytenava 7.5mg/0.3ml solution for injection vials
- 1.25 mginjectionManufacturer: Special Order
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 LYTENAVA
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.